Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP001282

Drug Information
NameInterferon beta-1a    
Synonyms145258-61-3; Avonex; D04554; Avonex (TN); Interferon beta-1a (genetical recombination) (JAN); Interferon beta-1a (genetical recombination); Interferon beta-1a (USAN); Interferon beta-1a    
Trade NameRebif; Avonex; Cinnovex    
IndicationMultiple sclerosisApproved    [1]
Therapeutic ClassImmunomodulatory Agents    
CAS NumberCAS 145258-61-3
FormularC908H1408N246O252S7    
PubChem Substance IDSID 47206399.    
TargetInterferon-alpha/beta receptorBinder[2]
Ref 1Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20. To Reference
Ref 2Effect of statins on clinical and molecular responses to intramuscular interferon beta-1a. Neurology. 2009 Jun 9;72(23):1989-93. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543